# FDA Inspection 1018449 - James Benjamin Renfroe MD - June 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/james-benjamin-renfroe-md/b835f1ae-97cd-4947-bdba-bcd965c045ad
Source feed: FDA_Inspections

> FDA Inspection 1018449 for James Benjamin Renfroe MD on June 30, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018449
- Company Name: James Benjamin Renfroe MD
- Inspection Date: 2017-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1174857 - 2022-07-14](https://www.keypedia.com/records/fda_inspections/james-benjamin-renfroe-md/ec3d3435-a02d-4b44-8e72-3baa41b42af6)

Company: https://www.keypedia.com/companies/james-benjamin-renfroe-md/c4ca1f27-d08a-4739-80c5-cc937295a403

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c